Healthcare related organizations worldwide are at the epicenter of utilizing microfluidic flow cells or flow cell cytometry to develop advanced medical solutions including those designed to address the current pandemic.
For example, the National Institutes of Health (NIH) just announced a $248M investment into technologies like flow cytometry that use a microfluidic "lab-on-a-chip" to increase SARS-CoV-2 (COVID-19) testing capacity, increase throughput, and reduce time to receive results.
Why this matters: Microfluidic flow cells are a crucial diagnostic tool. An increased demand means a greater need for quality assurance and inspections. Lumetrics precision optical metrology solutions make the inspection of such microfluidic flow cells possible.
learn more in our microfluidic flow cells app note.
